Retroviral protease inhibiting compounds

A use, in the preparation of a medicament for inhibiting HIV protease, of a compound of formula I, is disclosed. The use of a compound of formula I in combination with a reverse transcriptase inhibitor or a combination of reverse transcriptase inhibitors, in the preparation of a medicament for inhib...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: KEMPF, DALE J, HERRIN, THOMAS R, BETEBENNER, DAVID A, CONDON, STEPHEN L, SHAM, HING L, NORBECK, DANIEL W, STONER, ERIC J, COOPER, ARTHUR J, STENGEL, PETER J, TIEN, JIEH-HEH J, OLIVER, PATRICIA A, PLATA, DANIEL J, CHEN, XIAOQI, DICKMAN, DANIEL A, KOLACZKOWSKI, LAWRENCE, HANNICK, STEVEN M, PATEL, KETAN M, KUMAR, GONDI N, LIU, JIH-HUA
Format: Patent
Sprache:eng
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A use, in the preparation of a medicament for inhibiting HIV protease, of a compound of formula I, is disclosed. The use of a compound of formula I in combination with a reverse transcriptase inhibitor or a combination of reverse transcriptase inhibitors, in the preparation of a medicament for inhibiting an HIV infection is also disclosed. Further, a use, in the preparation of a medicament for inhibiting an HIV infection, of a pharmaceutically acceptable salt, ester or prodrug of the compound (2S, 3S, 5S)-2-(2,6-dimethylphenoxyacetyl) amino-3-hydroxy-5-(2S-(1-tetrahydropyrimi-2-only)-3-methyl butanoyl) amino-1,6-diphenylhexane; in combination with another HIV protease inhibitor or a combination if HIV protease inhibitors is disclosed.